Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 29, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Meprobamate, and what generic Meprobamate alternatives are available?

Meprobamate is a drug marketed by Pvt Form, Purepac Pharm, Watson Labs, Vangard, West Ward, Mylan, Nexgen Pharma Inc, Alembic Pharms Ltd, Impax Labs, Usl Pharma, Elkins Sinn, Heather, Barr, Whiteworth Town Plsn, Roxane, Solvay, Ivax Sub Teva Pharms, Lee Km, Pharmavite, Valeant Pharm Intl, Scherer Labs, Parke Davis, Perrigo, Sandoz, Ivc Inds, Aurolife Pharma Llc, Mk Labs, Mallard, Stanlabs Pharm, Lannett, Tablicaps, Invagen Pharms, Taro, Lederle, Sun Pharm Inds, and Par Pharm. and is included in forty-seven NDAs.

The generic ingredient in MEPROBAMATE is aspirin; meprobamate. There are twenty-one drug master file entries for this compound. Additional details are available on the aspirin; meprobamate profile page.

Summary for Tradename: MEPROBAMATE

Suppliers / Packagers: see list8
Bulk Api Vendors: see list22
Patent Applications: see list5,920
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MEPROBAMATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
TABLET;ORAL014547-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Valeant Pharm Intl
TABLET;ORAL015139-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
TABLET;ORAL084274-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Sun Pharm Inds
TABLET;ORAL080699-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Mk Labs
TABLET;ORAL014368-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus